Stingless bee (Meliponini) honey is a bioresource used to treat cataracts in traditional medicine. The anticataract activity of twenty flavonoids was explored in an osmotic cataract model, to find a probable link between the putative anti-cataract properties of stingless bee honey eyedrops and their flavonoids. Osmotic cataracts were induced in ovine lenses to produce a model to test anti-cataract drugs in cultured lenses by digital image analysis. Digital images were taken every 4 hr to monitor progressive opacification by measurements of grey level. In 24 hr. the opacification was stable. Osmotic cataracts were induced by incubating ovine lenses in 45% hypotonic HBS for 24 hr to test the anticataract action of twenty synthetic flavonoids at a concentration of 10 −5 M. Luteolin tetramethyl ether, luteolin 4 -glucoside, luteolin 3 -7-diglucoside and orientin, significantly inhibited cataracts induced in ovine lenses incubated in 45% hypotonic HBS for 24 hr. Different degrees of opacification were produced by hypotonic stress in ovine lenses. The significant inhibition of cataracts caused by four derivatives of luteolin in vitro may be considered as a preliminary evidence for the putative anticataract properties of stingless bee honeys.
INTRODUCTION
Ocular cataract is lens opacification. At least 50 million people suffer from cataract-related visual impairments, with 17 million being severely disabled. In the U.K., cataract is one of the four main causes of blindness. Half of the blindness in the world is due to cataract and this represent some 13 million people. 1) Surgery to implant intraocular lenses is the actual treatment of cataracts currently accepted. 2, 3) However, the prescription of anticataract agents of different nature is a common practice although their action on cataracts have not been properly supported by prospective clinical trials. 4) Following the sorbitol theory of cataractogenesis, 5) aldose reductase inhibitors (ARI) were studied as promising agents for the medical treatment of cataracts, and their action to inhibit the onset of cataracts has been tested both in vitro and in vivo. 6, 7) Some flavonoids have been reported as anticataract agents in several studies in vitro because of their action as ARI. 8 The use of stingless bee (Hymenoptera; Apidae; Meliponinae) honey as eyedrops to cure cataracts is a folk practice in tropical countries of America 11) dating back to the Mayas, 12) but there is no scientific evidence available on that ancient remedy. In a recent review of medicinal properties attributed to these non-Apis honey type, the treatment of pterygium is another benefit suggested for the topical application in the eyes. 13) Plant extracts are also added to stingless bee honey sold for eye treatment. 14) Flavonoids are found in honey as residual secondary plant metabolites, and have been studied for their potential use as botanical and geographical markers, [15] [16] [17] [18] [19] [20] and also to explain the antibacterial properties of honey. 21, 22) However, flavonoids have not been previously explored in connection with the putative anticataract attributes of honey. In a recent study, the flavonoid diversity of Apis mellifera honeys from Venezuela was similar to Melipona spp. but lower than the diversity reported for temperate honeys, 23) with frequent luteolin derivatives in the phenolic fraction. 24) An initial approach to validate the reputed anticataract properties of honey is a monofactorial study considering the effects of flavonoids present in honey on a cataract model in vitro, prior to any in vivo study. In the present work, a method was explored to produce in vitro controlled osmotic cataracts incubating ovine lenses in hypotonic culture media. This method was used to test the anticataract action of twenty synthetic flavonoids at a concentration of 10 −5 M.
MATERIALS AND METHODS
Culture Media --Hepes buffered solution (HBS) was the control solution used for lens culture. The HBS was prepared by dissolving 7.305 g NaCl (125 mM), 0.328 g KCl (4.4 mM), 0.840 g NaHC0 3 (10 mM), 2.383 g Hepes (10 mM), 0.900 g glucose (5 mM), 6 .864 g sucrose (20 mM), 2 ml 1 M CaCl 2 (2 mM) and 100 µl 5 M MgCl 2 (0.5 mM), to 800 ml of distilled water. The pH was adjusted to 7.4 with 1N HCl and 1N NaOH solutions. The final volume was brought up to 1 l with distilled water and the solution was sterilised with a 0.22 µm bottle top filter (Falcon 7105, from Becton Dickinson, Oxford, UK). The osmolality of the HBS was measured using an automatic cryoscopic osmometer (Osmomat 030, Gonotec, Berlin, Germany) and adjusted to 310 ± 10 mosmol kg −1 with distilled water. This solution was freshly prepared at the beginning of each experiment, and kept at 4 • C. To prevent infection, 2 ml antibiotics/100 ml HBS were added just before use. The stock antibiotic solution was made up with penicillin (5000 IU/ml) and streptomycin (5000 µg/ml). Eyes --Enucleated eyes from Ovis aries were obtained in a local abattoir within 1-2 hr post mortem and stored at 4 • C up to 2 hr before use.
Dissection of Eyes and Lens Preparation --
The ovine eyes were opened by a scalpel incision at the corneal limbus. The cornea was removed cutting with scissors around its junction with the sclera. The exposed lens was kept moist with HBS + P/S. The iris was held with forceps and gradually removed. Finally the suspensory ligaments were cut with fine curved scissors, the lens was removed with a loop and stored in a 50 ml sterile container with control culture medium. Lens Incubation --Three lenses were distributed at random for each treatment after prewarming to 37 • C in a humidified incubator (Gallenkampf, from Fisher Scientific, Loughborough, UK) for 15 hr prior to the experiment, to permit equilibration. Individual lenses were immersed in 5 ml of prewarmed HBS into a sterile glass tube (2.5 cm diameter). These experimental units were incubated in a plastic box at 37 • C to prevent evaporation. Osmotic Cataract Model --HBS solutions were modified by the addition of distilled water to make a series of hypotonic solutions: 30%, 35%, 40%, 45% and 50% hypotonic. Lenses were incubated as described above at 37 • C for 24 hr. These hypotonic solutions were found to induce opacification (cataract) of increasing severity. The degree of opcification was measured as detailed below. The opacification caused by both 45% and 50% hypotonic solutions was similar therefore 45% hypotonic solution was chosen to test the anti-cataract properties of flavonoids. Table 1 . Digital Images --Digital photographs of polar views of the lenses with a black background were periodically taken every 4 hr with a charged coupled device camera (CCD EDC-1000HR, Electrim Corporation, Princeton, New Jersey, USA), during 24 hr for the osmotic cataract model. For the flavonoid test, only initial (0 hr) and final (24 hr) images were saved. The conditions of the camera were set up with a black card as a standard for control. Measurements of Grey Level --The digital images of polar views were analysed with Quantimet Q500MC (Leica, Milton Keynes, UK) software to measure the mean grey level of the pixels contained in the image, a quantity referred to as density of white. The scale of grey level varies from 0 (black) to 255 (white). The measurements were done following the routine program Quantimet Image Processing Software (QUIPS, Leica) designed to locate the lens, to detect the threshold grey level in the border of the lens, to close it with a line when necessary, to fill holes, to subtract the border, to fill holes again, to reject areas outside the lens and finally to measure the average grey level of the pixels in the isolated two-dimensional image of the lens. The simplest cataract index to quantify different degrees 
RESULTS
Cataracts were successfully produced in all the hypotonic (30-50%) culture media. The progressive development of these osmotic cataracts was measured every four hours for 24 hr and is presented in Table 2 .
The lenses incubated in 30% and 35% hypotonic HBS, reached their maximum opacification in eight hours. At higher hypotonicity, the lenses required 16 hr to maximize their opacification. In 24 hr. the opacification was stable. Osmotic cataracts obtained with 45% and 50% hypotonic HBS overlapped in the final measurements, therefore the HBS 45% hypotonic was selected to produce cataracts in the present model.
The opacification of the lenses exposed to a 45% hypotonic HBS and flavonoids (10 −5 M) for 24 hr, is presented in Table 2 . All the treatments were significantly different (ANOVA one-way, α = 0.05) from the isotonic control because cataracts developed in the presence of any flavonoid, but with different severity. Only four of the flavonoids (luteolin tetra-methyl ether, luteolin 4 -glucosyde, luteolin 3 -7-diglucosyde and orientin) significantly reduced the opacification caused by the 45% hypotonic culture media, with average grey levels in the range 116.00-121.60 detected by the method as significantly different [analysis of variance (ANOVA) one-way, α = 0.05] from other tested flavonoids.
Both anterior and posterior cortical cataracts developed simultaneously, increasing their severity from the periphery to the centre of the lens, no nuclear cataracts were observed. Variations of cataract morphology according to cataract severity will be discussed elsewhere. Lenses treated with luteolin tetra-methyl-ether generated a characteristic pattern of opacification in their equatorial view; complete anterior and partial posterior cataracts occurred with an even ring-like band extending under the equator, leaving the posterior pole of the lens without opacification.
DISCUSSION
Osmotic cataracts produced by incubating ovine lenses in hypotonic culture media are simple in their nature of involving a water imbalance. The density of white increases with the hydration of the cells because their swelling scatters the light and alters the optical property of clarity in a normal lens. 25) The loss of transparency was visible after 4 hr of hypotonic stress and developed to a maximum of 120 grey level units from the basal value of 90 grey level units of the control in isotonic HBS. The osmotic stress generated by 45% hypotonic HBS was the minimum required to reach the maximum opacification detected with the method. Less severe treatments are more likely to recover in the presence of anticataract agents. Experimental recovery or cataract reabsorption has been observed in lenses incubated in 30% hypotonic HBS and returned to isotonic culture medium (unpublished data). The progression of experimental cataracts from the periphery to the polar regions of the lens will require a further different form of assessment to compare the equatorial band with the central polar area as a function of time.
Flavonoids are most commonly known for their antioxidant activity. However, interest in the context of the eye stems from their ability to inhibit aldose reductase, the enzyme implicated in the aetiology of cataract in diabetic and galactosemic rats. Over forty flavonoids were found to be inhibitors of aldose reductase, the two most potent being quercitrin and quercitrin-2 -acetate. 8) Subsequent in vivo tests, demonstrated that quercitrin decreased the accumulation of sorbitol and fructose in the lens, and delayed cataract formation in diabetic degus (small rodents). The aglycone quercetrin delayed lens damage in galactose fed rats. 26) Neither isoquercitrin nor quercetin reduced the opacification in our osmotic cataract model, indeed, there is some evidence that quercetin exacerbated the opacification. In this context it is interesting that quercetin has been shown to inhibit the Na + /K + -ATPase 27) and it has long been known that inhibition of the Na + /K + -ATPase causes cataract. 28) However, substituted derivatives of luteolin all caused a significant reduction in the degree of opacification after 24 hr.
In a different approach to assess the anticataract activity of commercial natural products by monitoring the inhibition of sorbitol metabolism using 13 Cnuclear magnetic resonance, methylated flavonoids were stronger inhibitors than the non methylated. 29) In the present work, both methyl and glucosyl substituents increased the percentage of cataract inhibition by the aglycone luteolin, except the 7-glucosyl, but it was also observed that only the methylated luteolin caused a distinctive pattern of complete cataract inhibition in the posterior pole of the lens. The explanation of this final observation requires further investigation.
Flavonoids have been shown to possess many properties; they inhibit a number of enzymes such as aldose reductase, xanthine oxidase, phosphodiesterase, Ca +2 -ATPase, lipoxygenase, cycloxygenase. They also have a regulatory role on different hormones like estrogens, androgens and thyroid hormone. 30) Different flavonoids exhibit different effects and specificities. Flavonoid aglycones have different properties to their glycosylated counterparts, at least in terms of their effect on phosphodiesterases. 31) In our study there was no correspondence between the flavonoids found by Varma and Kinoshita 8) to have aldose reductase inhibitory properties and the flavonoids preventing opacification in our model. They found di-, tri-, tetra-and penta-hydroxy flavonoids with inhibitory properties, both with and without glycosyl substitutions. We, on the other hand found that it was glycosylated or substituted tetrahydroxy-flavonoids that had the most pronounced effect. Di-, tri-and penta-hydroxy flavonoids were ineffective. We can infer therefore that the action is probably not via inhibition of aldose reductase.
Luteolin is a frequent flavonoid in the phenolic profile of Melipona spp. from Venezuela; 23, 24) therefore, the fact that in the present flavonoid screening, luteolin derivatives were more likely to be involved in a mechanism of cataract inhibition provides an interesting connection with the putative anticataract properties of stingless bee honeys. Due to the dual nature of honey, being both natural medicine and food, a complementary area for further investigation is the anticataract effect of dietary flavonoids derived from stingless honey. The wide use of honey for medicinal purposes demands pharmaceutical regulation besides its use as a food sweetener. Stingless bee honeys are not included in the Codex Alimentarius because only the sweet product kept in combs by Apis mellifera is currently defined as honey. 32) Therefore, the creation of regulations for stingless bee honey are a must to control the quality of eye drops for this traditional anticataract practice to be adopted in modern medicine.
Reviewed aspects on anti-inflammatory action, antioxidant activity, stimulation of cell growth, the release of hydrogen peroxide, and the harmlessness of honey provide the therapeutical rationale for the use of honey as a standard medicine. 33) However, the mechanisms suggested to explain the effectiveness of honey as a medicine need the understanding of its multifactorial composition and multivariate nature causing systemic or localized physiological responses. Honey is a healing fluid with more variation than any medicinal herb because nectar is originated from different plants. In this context, the work done on sensorial evaluation of honey, initiated in France, 34) has provided extensive knowledge on how different is one honey from another with different botanical origin. In 1990 an International Honey Commission, chaired by Dr. Bogdanov, was created to review the official methods of Apis mellifera honey analysis. A recent proposal to expand honey standards to all species of bees, foresee the adoption of analytical methods used to assess and to harmonize chemical composition and botanical origin of Apis mellifera honey, but also needs new methods to identify the entomological origin. 35) Admirable contributions to inform apidologists and the public on honey types can be illustrated by ministerial projects like the guide to value honey according to denominations of origin 36) and the special issue of Apidologie (2005) on European unifloral honeys. 37) This year, special attention was also given to the flavonoid content of food, including 2.5 mg/100 g honey. 38) The domestication of stingless bees to facilitate honey harvesting, will be merited if their anticataract properties are sufficiently demonstrated. Technical solutions for the design of stingless bee hives already exist, 39) but integrated efforts addressed to meliponiculture, such as the Regional Programme on Tropical Beekeeping in Costa Rica, 40) are also necessary for a consistent progress in the quality control of this ancient honey. Stingless bee eyedrops could be applied prior to the consideration of surgical solutions, together with preventive nutritional approaches 41) and protective habits against environmental UV light 42) to delay the onset of cataracts.
This study provides initial results to approach the understanding of an ancient belief on the use of honey to clarify vision. Flavonoids are one of the possible active principles contained in honey. However, due to the chemical diversity of the nature and position of substituents, not all flavonoids have anticataract action. Here, we demonstrated that four structures of the luteolin family caused reduction of opacification in a lens culture model for osmotic cataract.
